Gene · 1815
Papers4,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-level variations of lateral habenula in depression: A comprehensive review of current evidence. | Front Psychiatry | 2022 | 36386995 | PubTator, text mining | PubMed |
| Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer: Insights and future perspectives. | Asian J Pharm Sci | 2022 | 36382305 | PubTator, text mining | PubMed |
| Capability of Human Dendritic Cells Pulsed with Autologous Induced Pluripotent Stem Cell Lysate to Induce Cytotoxic T Lymphocytes against HLA-A33-Matched Cancer Cells. | Int J Mol Sci | 2022 | 36361783 | PubTator, text mining | PubMed |
| The Genetics of Risk Aversion: A Systematic Review. | Int J Environ Res Public Health | 2022 | 36361187 | PubTator, text mining | PubMed |
| Special Issue: Genetics of Psychiatric Disease and the Basics of Neurobiology. | Genes (Basel) | 2022 | 36360245 | PubTator, text mining | PubMed |
| Genetic Variations between Youth and Professional Development Phase English Academy Football Players. | Genes (Basel) | 2022 | 36360238 | PubTator, text mining | PubMed |
| Antipsychotics in the Management of Disruptive Behavior Disorders in Children and Adolescents: An Update and Critical Review. | Biomedicines | 2022 | 36359338 | PubTator, text mining | PubMed |
| Dopamine increases risky choice while D2 blockade shortens decision time. | Exp Brain Res | 2022 | 36350356 | PubTator, text mining | PubMed |
| Review and Meta-analysis on the Impact of the ADRA2A Variant rs1800544 on Methylphenidate Outcomes in Attention-Deficit/Hyperactivity Disorder. | Biol Psychiatry Glob Open Sci | 2022 | 36325160 | PubTator, text mining | PubMed |
| Personality disorders, depression and anxiety in mothers of children with ADHD and anxiety disorders in Iran. | J Mother Child | 2022 | 36317794 | PubTator, text mining | PubMed |
| Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives. | Front Pharmacol | 2022 | 36313375 | PubTator, text mining | PubMed |
| Characterization of Ferroptosis-Related Molecular Subtypes with Immune Infiltrations in Neuropathic Pain. | J Pain Res | 2022 | 36311291 | PubTator, text mining | PubMed |
| Ventral tegmental area dopaminergic action in music therapy for post-traumatic stress disorder: A literature review. | Front Psychol | 2022 | 36300072 | PubTator, text mining | PubMed |
| Biological Predictors of Treatment Response in Adult Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review. | J Pers Med | 2022 | 36294881 | PubTator, text mining | PubMed |
| Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry? | J Pers Med | 2022 | 36294858 | PubTator, text mining | PubMed |
| Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders. | Front Immunol | 2022 | 36268024 | PubTator, text mining | PubMed |
| Functional and pharmacological role of the dopamine D4 receptor and its polymorphic variants. | Front Endocrinol (Lausanne) | 2022 | 36267569 | PubTator, text mining | PubMed |
| DNA Methylation Pattern of Gene Promoters of MB-COMT, DRD2, and NR3C1 in Turkish Patients Diagnosed with Schizophrenia. | Clin Psychopharmacol Neurosci | 2022 | 36263643 | PubTator, text mining | PubMed |
| Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review. | Front Pharmacol | 2022 | 36263121 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking Analyses Unveil the Mechanisms of Yiguanjian Decoction against Parkinson's Disease from Inner/Outer Brain Perspective. | Biomed Res Int | 2022 | 36237735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1815/papers?page=20